Global DNA Gene Chip Market Growth (Status and Outlook) 2023-2029
DNA gene chips or DNA microarrays are tiny chips that are engrafted with DNA molecules. A DNA gene chip size resembles the size of a postage stamp. A DNA microarray consists of a set of microscopic DNA spots attached on a solid surface. Every DNA spot consists of picomoles of a definite DNA sequence, known as probes. These probes can be a small section of a gene or a DNA element that are used to hybridize a cRNA or cDNA sample (called target) under stringent conditions. These powerful and versatile arrays are frequently used in genetic and medicinal research owing to their ability to speed up the research process.
LPI (LP Information)' newest research report, the “DNA Gene Chip Industry Forecast” looks at past sales and reviews total world DNA Gene Chip sales in 2022, providing a comprehensive analysis by region and market sector of projected DNA Gene Chip sales for 2023 through 2029. With DNA Gene Chip sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world DNA Gene Chip industry.
This Insight Report provides a comprehensive analysis of the global DNA Gene Chip landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on DNA Gene Chip portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global DNA Gene Chip market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for DNA Gene Chip and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global DNA Gene Chip.
The global DNA Gene Chip market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
North America is the largest DNA gene chip market owing to favorable government policies and increase in incentives along with technological advancement in DNA gene chip. Europe is the second largest market for DNA gene chip due to growing prevalence of cancer, increasing government initiatives, and rising demand for early detection and diagnosis of cancer.
This report presents a comprehensive overview, market shares, and growth opportunities of DNA Gene Chip market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
CDNA (Complementary DNA)
ODNA (Oligonucleotide DNA)
Segmentation by application
Gene Expression
Cancer Diagnostics & Treatments
Drug Discovery
Genetics
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Illumina, Inc.
Agilent Technologies, Inc.
Roche Nimblegen
Sequenom Inc.
Applied Microarrays
Please note: The report will take approximately 2 business days to prepare and deliver.